COX-2/sEH Dual Inhibitor PTUPB Potentiates the Anti-tumor Efficacy of Cisplatin

Cisplatin-based therapy is highly toxic, but moderately effective in most cancers. Concurrent inhibition of cyclooxygenase-2 (COX-2) and soluble epoxide hydrolase (sEH) results in anti-tumor activity, and has organ protective effects. The goal of this study was to determine the anti-tumor activity o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Main Authors: Wang, Fuli, Zhang, Hongyong, Ma, Ai-Hong, Yu, Weimin, Zimmermann, Maike, Yang, Jun, Hwang, Sung Hee, Zhu, Daniel, Lin, Tzu-yin, Malfatti, Michael, Turteltaub, Kenneth W, Henderson, Paul T., Airhart, Susan, Hammock, Bruce D., Yuan, Jianlin, de Vere White, Ralph W., Pan, Chong-Xian
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824635/
https://ncbi.nlm.nih.gov/pubmed/29284644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0818
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares